From: Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B
Fatty acids | Odds ratio (95% confidence interval) | P value | ||||
---|---|---|---|---|---|---|
1st Quartile Reference | 2nd Quartile | 3rd Quartile | 4th Quartile | 5th Quartile | ||
C – 14:0 | 1.00 | 1.7 (0.1–21.3) | 3.3 (0.4–29.0) | 3.1 (0.4–25.2) | 4.7 (0.2–212.2) | < 0.01 |
C - 16: 0 | 1.00 | 1.4 (0.2–9.6) | 1.7 (0.2–12.3) | 1.7 (0.2–14.6) | 3.2 (0.1–121.0) | < 0.01 |
C - 18: 0 | 1.00 | 1.4 (0.2–10.9) | 1.2 (0.1–13.7) | 1.1 (0.2–6.6) | 2.4 (0.1–93.9) | 0.26 |
C - 20: 0 | 1.00 | 1.7 (0.1–24.2) | 2.1 (0.4–11.4) | 2.2 (0.3–19.8) | 3.3 (0.2–118.8) | 0.29 |
C - 16: 1 | 1.00 | 3.0 (0.2–96.4) | 3.4 (0.2–103) | 3.0 (0.03–904) | 3.6 (0.2–125.9) | 0.11 |
C - 18: 1 | 1.00 | 1.2 (0.1–16.3) | 1.9 (0.2–14.8) | 2.0 (0.2–19.7) | 3.3 (0.1–158.8) | 0.15 |
C - 22: 1 | 1.00 | 2.4 (0.3–22.6) | 2.7 (0.2–35.8) | 2.2 (0.3–16.9) | 2.0 (0.03–117) | 0.29 |
C - 18: 2 | 1.00 | 0.6 (0.1–4.1) | 0.4 (0.02–4.3) | 0.2 (0.01–3.6) | 0.1 (0.003–2.4) | < 0.01 |
C - 18: 3 | 1.00 | 0.2 (0.01–1.9) | 0.5 (0.1–3.4) | 0.4 (0.1–2.7) | 0.2 (0.01–5.1) | 0.03 |
C - 20: 3 | 1.00 | 0.2 (0.02–1.4) | 0.2 (0.01–2.6) | 0.4 (0.1–2.3) | 0.2 (0.01–4.8) | 0.02 |
C - 20: 4 | 1.00 | 0.6 (0.1–5.5) | 0.8 (0.1–5.4) | 0.8 (0.1–6.5) | 0.8 (0.01–42.6) | < 0.01 |
C - 20: 5 | 1.00 | 0.5 (0.04–4.6) | 0.5 (0.04–4.6) | 0.5 (0.1–3.4) | 0.3 (0.01–6.3) | 0.003 |
C - 22: 5 | 1.00 | 1.0 (0.1–8.2) | 1.0 (0.1–8.2) | 1.0 (0.01–53) | 1.2 (0.2–8.4) | 0.05 |
C - 22: 6 | 1.00 | 0.8 (0.1–7.5) | 0.7 (0.1–4.8) | 0.8 (0.1–5.8) | 0.8 (0.01–42.6) | 0.25 |